FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for Unresectable or Metastatic Non-Small Cell Lung Cancer with Activating HER2 MutationsGautam U. Mehta,Paz J. Vellanki, Yi Ren,Anup K. Amatya,Pallavi S. Mishra-Kalyani, Lili Pan,Jeanne F. Zirkelbach,Yuzhuo Pan,Jiang Liu,Stephanie L. Aungst,Claudia P. Miller,Mirat Shah,Nam Atiqur Rahman,Marc Theoret,Paul Kluetz,Richard Pazdur,Julia A. Beaver,Harpreet SinghThe Oncologist(2024)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要